{"id":"36824567","title":"Global Atomic Provides 2025 Summary and 2026 Outlook","author":null,"feed":"PRTGAM","feedName":"Newswire.ca","published":"Tue Dec 30, 2025","image":"N/A","content":"

TORONTO, Dec. 30, 2025 /CNW/ - Global Atomic Corporation ("Global Atomic" or the "Company"), (TSX: GLO) (OTCQX: GLATF) (FRANKFURT: G12) today provided a summary of 2025 and its outlook for 2026.

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

","related":[{"id":"2642122","title":"Guotai Haitong Remains a Buy on OneRobotics (Shenzhen) Co., Ltd. Class H (6600)","slug":"guotai-haitong-remains-a-buy-on-onerobotics-shenzhen-co-ltd-class-h-6600","feedName":"Tipranks","published":"1 minute ago","categories":[]},{"id":"2642120","title":"Barclays Keeps Their Buy Rating on NetApp (NTAP)","slug":"barclays-keeps-their-buy-rating-on-netapp-ntap","feedName":"Tipranks","published":"1 minute ago","categories":[]},{"id":"2642118","title":"Barclays Sticks to Its Buy Rating for Natera (NTRA)","slug":"barclays-sticks-to-its-buy-rating-for-natera-ntra","feedName":"Tipranks","published":"1 minute ago","categories":[]},{"id":"2642116","title":"Barclays Sticks to Its Buy Rating for Guardant Health (GH)","slug":"barclays-sticks-to-its-buy-rating-for-guardant-health-gh","feedName":"Tipranks","published":"1 minute ago","categories":[]},{"id":"2642114","title":"Nidec Probes Ransomware Attack on Taiwanese Subsidiary","slug":"nidec-probes-ransomware-attack-on-taiwanese-subsidiary","feedName":"Tipranks","published":"1 minute ago","categories":[]},{"id":"2642112","title":"Barclays Reaffirms Their Buy Rating on 10x Genomics (TXG)","slug":"barclays-reaffirms-their-buy-rating-on-10x-genomics-txg","feedName":"Tipranks","published":"2 minutes ago","categories":[]},{"id":"2642110","title":"Barclays Sticks to Their Sell Rating for Illumina (ILMN)","slug":"barclays-sticks-to-their-sell-rating-for-illumina-ilmn","feedName":"Tipranks","published":"2 minutes ago","categories":[]},{"id":"2642108","title":"Barclays Sticks to Their Buy Rating for Repligen (RGEN)","slug":"barclays-sticks-to-their-buy-rating-for-repligen-rgen","feedName":"Tipranks","published":"2 minutes ago","categories":[]},{"id":"2642106","title":"Japan Display Shareholders Back Capital Restructuring and Governance Moves","slug":"japan-display-shareholders-back-capital-restructuring-and-governance-moves","feedName":"Tipranks","published":"2 minutes ago","categories":[]}],"sourceId":"newswireca-2025-12-30-global-atomic-provides-2025-summary-and-2026-outlook","media":"text","thumbnail":"N/A","canonicalUrl":"https://www.newswire.ca/news-releases/global-atomic-provides-2025-summary-and-2026-outlook-881217590.html","feedUrl":null,"slug":"global-atomic-provides-2025-summary-and-2026-outlook"}

Latest in

More

Global Atomic Provides 2025 Summary and 2026 Outlook